Nowadays, biocatalysts have received much more attention in chemistry regarding their potential to enable high efficiency, high yield, and eco-friendly processes for a myriad of applications. Nature’s vast repository of catalysts has inspired synthetic chemists. Furthermore, the revolutionary technologies in bioengineering have provided the fast discovery and evolution of enzymes that empower chemical synthesis. This article attempts to deliver a comprehensive overview of the last two decades of investigation into enzymatic reactions and highlights the effective performance progress of bio-enzymes exploited in organic synthesis. Based on the types of enzymatic reactions and enzyme commission (E.C.) numbers, the enzymes discussed in the article are classified into oxidoreductases, transferases, hydrolases, and lyases. These applications should provide us with some insight into enzyme design strategies and molecular mechanisms.

Plastic contamination in agricultural systems is an emerging concern. While current research suggests low direct toxicity, the consequences from interactions between nanoplastics and copresent contaminants are poorly understood. In this study, the synergistic effects of cadmium (Cd) and polystyrene nanoplastics (PS NP) on the growth and physiological responses of hydroponically grown Lactuca sativa (lettuce) were examined. Coexposure significantly increased the accumulation of Cd and PS NP by 61 and 67% in lettuce shoots compared with single-contaminant exposure. Metabolomic analysis showed that joint exposure induced an increase in glutathione and flavonoid-like compounds, suggesting an energy-intensive oxidative stress response. In addition, coexposure appeared to promote adventitious root formation, as evidenced by an increased abundance of metabolites linked to nitric oxide signaling. These findings suggest that the projected increase in PS NP in agricultural environments could exacerbate Cd uptake in food crops, potentially increasing human dietary exposure to heavy metals.

Per- and polyfluoroalkyl substances (PFASs) have gained significant attention due to their widespread distribution in the environment and potential adverse health effects. While ingestion, especially through contaminated drinking water, is considered the primary route of human exposure, recent research suggests that other pathways, such as inhalation and dermal absorption, also play a significant role. This review provides a concise overview of the toxicological impacts of both legacy and emerging PFASs, such as GenX and perfluorobutane sulfonic acid (PFBS), with a particular focus on their effects on the liver, kidneys, and immune and nervous systems, based on findings from recent in vivo, in vitro, and epidemiological studies. Despite the transition to PFAS alternatives, much of the existing toxicity data focus on a few legacy compounds, such as perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS), which have been linked to adverse immune outcomes, particularly in children. However, evidence for carcinogenic risk remains limited to populations with extremely high exposure levels, and data on neurodevelopmental effects remain underexplored. While epidemiological and experimental animal studies supported these findings, significant knowledge gaps persist, especially regarding emerging PFASs. Therefore, this review examines the visceral, neural, and immunotoxicity data for emerging PFASs and mixtures from recent studies. Given the known risks from well-studied PFASs, a precautionary principle should be adopted to mitigate human health risks posed by this large and diverse group of chemicals.

A simple, sensitive, and selective solid phase extraction – ultra-fast liquid chromatography – tandem mass spectrometry (SPE-UFLC-MS/MS) method was developed and applied for the analysis of selected important pharmaceutical compounds in source and finished drinking waters. The method detected the following six pharmaceuticals, cotinine, cephapirin, ciprofloxacin, enrofloxacein, azithromycin, and diphenhydramine, at sub-μg/L level in multiple water matrices after pre-concentration by SPE. Cotinine-d₃ and ¹³C₃¹⁵ N-Ciprofloxacin were used as internal standards for accurate quantitation. This method was validated through spike recoveries (67–129%), reproducibility (RSD: 2.3–15.7%), and method detection limits (MDLs: 2–5 ng/L). The method was used to test for occurrence of these pharmaceuticals in source and drinking waters from 13 Missouri water treatment facilities in four different seasons. In general, higher detection frequency and concentrations of pharmaceuticals were observed in colder months due presumably to less dilution (at lower flows) and slower degradation. The PPCP removals by different activated carbons were also evaluated. The occurrence and removal results in this study provide valuable information to help water treatment facilities taking appropriate strategies for better control of trace pharmaceuticals in drinking water.